Skip to main content
. 2026 Jun 26;27(13):5796. doi: 10.3390/ijms27135796
ASO Antisense oligonucleotide
CAF Cancer-associated fibroblast
CNS Central nervous system
CRC Colorectal cancer
ctDNA Circulating tumor DNA
ECM Extracellular matrix
EGFR Epidermal growth factor receptor
EMT Epithelial-to-mesenchymal transition
FDA U.S. Food and Drug Administration
FTI Farnesyltransferase inhibitor
GAP GTPase-activating protein
GDP Guanosine diphosphate
GEF Guanine nucleotide exchange factor
GTP Guanosine triphosphate
HR Hazard ratio
MAPK Mitogen-activated protein kinase
MEK Mitogen-activated protein kinase kinase
mCRC Metastatic colorectal cancer
MRD Minimal residual disease
NSCLC Non-small-cell lung cancer
ORR Objective response rate
OS Overall survival
PDAC Pancreatic ductal adenocarcinoma
PFS Progression-free survival
PI3K Phosphoinositide 3-kinase
PROTAC Proteolysis-targeting chimera
RAF Rapidly accelerated fibrosarcoma kinase
RAS(ON) Active-state RAS
RTK Receptor tyrosine kinase
SHP2 Src homology region 2-containing protein tyrosine phosphatase 2
S-IIP Switch-II pocket
siRNA Small interfering RNA
SOS1 Son of sevenless homolog 1
TME Tumor microenvironment